Julie Gormley has over 15 years’ experience working within the biotech and pharma industry.  She completed her PhD in protein directed evolution at the University of Nottingham in 2005 and started her career working as a Research Scientist and Senior Scientist at Fusion Antibodies before transitioning into Business Development. She continued her career in Business Development and Commercialisation taking positions at Redx Pharma, UK, and the University of Liverpool, UK. Julie returned to Fusion Antibodies in 2017 as a Business Development Director focussed on driving growth, with establishment of key accounts and collaborations to build long-term value for the company. Julie was appointed Commercial Senior Director in 2021.